Discovery of Rogaratinib (BAY 1163877): a pan-FGFR Inhibitor.
ChemMedChem
; 13(5): 437-445, 2018 03 06.
Article
em En
| MEDLINE
| ID: mdl-29451369
ABSTRACT
Rogaratinib (BAY 1163877) is a highly potent and selective small-molecule pan-fibroblast growth factor receptor (FGFR) inhibitor (FGFR1-4) for oral application currently being investigated in phaseâ
1 clinical trials for the treatment of cancer. In this publication, we report its discovery by deâ
novo structure-based design and medicinal chemistry optimization together with its pharmacokinetic profile.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Piperazinas
/
Pirróis
/
Tiofenos
/
Inibidores de Proteínas Quinases
/
Receptor Tipo 1 de Fator de Crescimento de Fibroblastos
/
Bibliotecas de Moléculas Pequenas
/
Descoberta de Drogas
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article